HYDERABAD, India, September 30, 2016 /PRNewswire/ --
Mordor Intelligence announces the publication of their research report on the high throughput screening market. The report titled, "Global High Throughput Screening Market - Growth, Trends and Forecast," discusses the current landscape and outlook of the market.
The global high throughput screening (HTS) market is estimated to be USD 16.75 billion in 2016 and is expected to reach USD 22.68 billion by 2021, projecting a CAGR of 6.25% during the forecast period. The report is an amalgamation of the current market scenario, its prospects and forces driving and restraining the market growth. The report highlights the North American, European, Asia-Pacific, Latin American and Middle East & African markets.
An increasing surge in demand for drug discovery services and the advent of new CRO's are factors expected to further expand this rapidly evolving market. Owing to recent advances, HTS drug discovery is expected to advance from purified proteins and intact cells to the use of entire intact living organisms.
Browse Related Report Here
The market for high throughput screening can be segmented based on technology (ultra-high-throughput screening (uHTS), cell-based assay, lab-on-a-chip, label-free technology, bioinformatics), by application (target identification, primary screening, toxicology, stem cell biology), by product (instruments, consumable/reagent, software & service) and by end-user (pharmaceutical, biotechnology, academia & government organizations, contract research organizations) and by geography (North America, Europe, Asia-Pacific and Rest of the World).
High throughput screening (HTS) is a popular approach to target validation as it allows the assaying of a large number of potential biological modulators against a chosen set of defined targets and is capable of screening millions of substances over a period of 1 week. North America is currently the largest high throughput screening market globally, followed by Europe. Countries in the Asia-Pacific region are one of those places where this market is rapidly growing due to increasing development and production of vaccines, drugs, & new biologics, increasing government and corporate investment in the biotechnology and pharmaceutical sector, increasing median age of the population and presence of high unmet market demand.
The leading companies that dominate the high throughput screening market Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.), Accelrys, Inc. (USA), Aurora Biomed Inc. (Canada) and Tecan Group (Switzerland).
About Mordor Intelligence:
Mordor Intelligence is a global market research and consulting firm. Our focus is to provide research insights to facilitate business success. Our research expertise covers niche segments under Agriculture, Healthcare, ICT, Chemicals, Manufacturing, Logistics, Electronics and Automotive, among others. We believe in data, and we provide solutions through it. Optimum solutions and goal-oriented strategies define our endeavors and make us the preferred choice for clients.
For information regarding permissions and sales, please contact: firstname.lastname@example.org
AVP - Marketing & Strategy
Direct Line: +1 617-765-2493
Last updated on: 30/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.